Dustin Haines, CEO EchoIQ

Mr Haines has 25 years’ experience in leading global businesses in pharmaceuticals, biotechnology, and medical devices. As the current CEO of EchoIQ, Mr. Haines focuses on the intersection of innovative technology utilizing AI and the impact of cardiovascular disease around the world. Prior to EchoIQ, Mr. Haines was head of Asia, Middle East, Turkey, and Russia for a major biotechnology company where he managed over $1.2B in revenue. Prior to that Mr. Haines was the commercial leader for a publicly traded medical device company in the United States, where he built go to market strategy and launched several new novel devices into the US market. As a leader, Mr. Haines has launched innovative technologies globally with extensive experience in regulatory approvals, reimbursement, commercialization, and scaling businesses.

Mr. Haines has a rich history of building high performing teams with a focus on aligning purpose with clear strategy. Inspired by nearly 20 years of working in infectious disease and seeing firsthand the power of patient engagement and partnership, Mr. Haines has been focused on working closely with patient organizations, community-based groups, physicians, and government health systems to bridge the gap of healthcare access and treatment.

Mr. Haines is currently residing in Arizona where he manages the day-to-day activities for EchoIQ covering both the US and Australian teams.